Condition: Chronic Kidney Disease Requiring Hemodialysis · End-Stage Kidney Disease (ESKD) · Chronic Kidney Disease Requiring Chronic Dialysis · Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
The goal of this clinical trial is to evaluate the health effects of expanded hemodialysis in patients receiving hemodialysis. The main question it aims to answer is: 1\) Does expanded hemodialysis reduce the risk of death from any cause? Researchers will compare expanded hemodialysis to conventional hemodialysis (the treatment currently used for the majority of patients receiving hemodialysis) to see if expanded hemodialysis works to improve patient outcomes. Participants will continue to receive their regularly scheduled hemodialysis treatments using either a super high-flux/expanded dialysis filter or a high-flux/conventional dialysis filter. All other aspects of treatments remain the same. No additional tests or visits are required. Data will be obtained using administrative healthcare databases and medical record review (at a subset of participating locations).
This description comes directly from the study's public registry record.
Pavel S Roshanov, MD MSc FRCPC · 519-663-3350 · pavel.roshanov@lhsc.on.ca
Central Research Coordinator · fixdialysis@lhsc.on.ca
Always discuss trial participation with your own doctor first.
| London Health Sciences Centre | London, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06660277